Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiichi Sato

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Viruses|April 23, 2022
Prognosis of Indolent Adult T-Cell Leukemia/LymphomaTakuro Kameda, Kotaro Shide, Yuki Tahira, et al.
International Journal of Hematology|March 1, 2018
Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, JapanAyako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 24, 2025
Screening of 1-Month-Old Infants With Prolonged QT Interval and Its Cutoff ValueMasao Yoshinaga, Hiroya Ushinohama, Seiichi Sato, et al.
Heart and Vessels|March 13, 2020
A significance of school screening electrocardiogram in the patients with ventricular noncompactionKeiichi Hirono, Nariaki Miyao, Masao Yoshinaga, et al.
International Journal of Hematology|March 11, 2025
Effects of tucidinostat in adult T-cell leukemia/lymphoma in clinical practiceAyako Kamiunten, Takuro Kameda, Masaaki Sekine, et al.
Heart Rhythm|August 25, 2022
Disrupted Ca<sub>V</sub>1.2 selectivity causes overlapping long QT and Brugada syndrome phenotypes in the CACNA1C-E1115K iPS cell modelAsami Kashiwa, Takeru Makiyama, Hirohiko Kohjitani, et al.
The Lancet. Haematology|December 22, 2015
Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trialJun Imagawa, Hideo Tanaka, Masaya Okada, et al.
Journal of Cardiology|August 22, 2022
Status of adult outpatients with congenital heart disease in Japan: The Japanese Network of Cardiovascular Departments for Adult Congenital Heart Disease RegistryAtsushi Yao, Ryo Inuzuka, Atsushi Mizuno, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 7, 2021
Electrocardiographic Diagnosis of Hypertrophic Cardiomyopathy in the Pre- and Post-Diagnostic Phases in Children and AdolescentsMasao Yoshinaga, Hitoshi Horigome, Mamoru Ayusawa, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 4, 2018
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line TreatmentMasaya Okada, Jun Imagawa, Hideo Tanaka, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Viruses|April 23, 2022
Prognosis of Indolent Adult T-Cell Leukemia/LymphomaTakuro Kameda, Kotaro Shide, Yuki Tahira, et al.
International Journal of Hematology|March 1, 2018
Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, JapanAyako Kamiunten, Kotaro Shide, Takuro Kameda, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 24, 2025
Screening of 1-Month-Old Infants With Prolonged QT Interval and Its Cutoff ValueMasao Yoshinaga, Hiroya Ushinohama, Seiichi Sato, et al.
Heart and Vessels|March 13, 2020
A significance of school screening electrocardiogram in the patients with ventricular noncompactionKeiichi Hirono, Nariaki Miyao, Masao Yoshinaga, et al.
International Journal of Hematology|March 11, 2025
Effects of tucidinostat in adult T-cell leukemia/lymphoma in clinical practiceAyako Kamiunten, Takuro Kameda, Masaaki Sekine, et al.
Heart Rhythm|August 25, 2022
Disrupted Ca<sub>V</sub>1.2 selectivity causes overlapping long QT and Brugada syndrome phenotypes in the CACNA1C-E1115K iPS cell modelAsami Kashiwa, Takeru Makiyama, Hirohiko Kohjitani, et al.
The Lancet. Haematology|December 22, 2015
Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trialJun Imagawa, Hideo Tanaka, Masaya Okada, et al.
Journal of Cardiology|August 22, 2022
Status of adult outpatients with congenital heart disease in Japan: The Japanese Network of Cardiovascular Departments for Adult Congenital Heart Disease RegistryAtsushi Yao, Ryo Inuzuka, Atsushi Mizuno, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 7, 2021
Electrocardiographic Diagnosis of Hypertrophic Cardiomyopathy in the Pre- and Post-Diagnostic Phases in Children and AdolescentsMasao Yoshinaga, Hitoshi Horigome, Mamoru Ayusawa, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 4, 2018
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line TreatmentMasaya Okada, Jun Imagawa, Hideo Tanaka, et al.
Pageof 9